Financing led by Biotech Specialist Funds and a Generalist with significant participation from Series A investors Proceeds will support the Phase 3 Program for patients with Cannabis Use Disorder PleoPharma, Inc., a privately held company focused on finding treatments for cannabis-related health issues, announced today the closing of a $36MM Series B financing round. https://mma.prnewswire.com/media/2497000/PleoPharma_Logo.jpg […]
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
70 GGBooks revealed by the Canada Council The Canada Council for the Arts is pleased to announce the 2025 Governor General's Literary Awards (GGBooks) finalists. These awards celebrate works published in Canada, in both official languages, across seven categories, and include books for readers of all ages. https://mma.prnewswire.com/media/2800970/Canada_Council_for_the_Arts_Discover_the_2025_Governor_General_s.jpg “The books selected as 2025 Governor General's
(Neo:ABXX.NE),(OTC US:ABXXF),(Other OTC:ABXXF), TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX) (“Abaxx” or the “Company“), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing“), and producer of the SmarterMarkets(TM) Podcast, today announced continued
Formerly Axial Therapeutics, Vertero is rapidly advancing a novel approach to address peripheral drivers of challenging neurodegenerative diseases Lead candidate VT-5006 is a first-in-class small molecule designed to precisely engage a validated target in the GI wall to slow the progression of Parkinson's disease $20M Series D financing supports Vertero's near-term goals and plans for
(NASDAQ:DFLI),(NASDAQ:DFLIW), RENO, Nev., Oct. 21, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced that it has received a letter (the “Letter”) on October 20, 2025 from the Nasdaq Hearings Panel of the Nasdaq Stock Market LLC (“Nasdaq”)
(TSX-V:DGX),(NASDAQ:DGXX), MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Digi Power X Inc. (“Digi Power X” or the “Company“) (Nasdaq: DGXX / TSXV: DGX), a U.S. developer of Tier III-grade high-performance computing (“HPC”) infrastructure, announced today that it is expanding its AI data center capacity with the addition of five new ARMS-200 GPU modules, scheduled to
(NASDAQ:BENF), DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, today reported its financial results for the fiscal 2026 first quarter, which ended
Ready-to-use preformed antibiotic loaded spacers for hip, knee and shoulder revisions Choice of Charnley and Müller hip spacer designs, and left and right geometries for each knee Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces the launch
(TSX:BCT),(NASDAQ:BCTX),(NASDAQ:BCTXW),(NASDAQ:BCTXZ), Collaboration with MSK's Therapeutics Accelerator Program includes manufacturing, IND and clinical development support of the Bria-OTS+(TM) platform, which includes Bria-BRES+(TM) for breast cancer PHILADELPHIA and VANCOUVER, British Columbia, Oct. 21, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company“), a clinical-stage biotechnology company that develops novel